surmount-1 tirzepatide weight loss non-diabetic SURMOUNT‐1 study design. This is a phase 3, multicenter, randomized, surmount-1 tirzepatide non-diabetic obesity trial

What to look for: A high-quality non-dairy protein powder (pea protein or other plant-based options) is ideal for GLP-1 users because it is gentle on the stomach and easier to tolerate when nausea is a factor

Halliwell, B., Zhao, K

Neurosci Lett 33: 305310

(2013) 3:e299

In particular, LC3B and SQSTM1, two major autophagy regulators, are significantly upregulated alongside increased GFAP expression

Overall, HT pathogenesis results from a complex interplay between innate and adaptive immunity, where breakdowns in tolerance, skewed Th1/Th17/Treg balance, and persistent autoantibody production sustain chronic inflammation and irreversible thyroid destruction